Meclozine/MemantineVarious toxicity following drug overdose and treatment non-compliance

被引：0

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2006卷 / 1期

关键词：

D O I：

10.1007/s40278-024-58283-3

中图分类号：

学科分类号：

摘要：

引用

页码：388 / 388

共 50 条

[1] InsulinDiabetic-ketoacidosis following treatment non-compliance
Reactions Weekly, 2023, 1984 (1) : 273 - 273
[2] Treatment non-compliance
Gonzalez Gonzalez, J.
Perez Escobar, J.
Maria Garcia Garcia, L. J.
Sanchez Holgado, J.
Criado-Alvarez, J. J.
REVISTA DE CALIDAD ASISTENCIAL, 2015, 30 (01) : 44 - 45
[3] A child and parent illustrating non-compliance with treatment: understanding non-compliance with treatment
Oppenheim, D
Hartmann, O
Ablin, A
Sourkes, B
BULLETIN DU CANCER, 2002, 89 (06) : 643 - 647
[4] AmfetamineDilated cardiomyopathy and pulmonary edema following drug misuse and treatment non-compliance: case report
Reactions Weekly, 2025, 2054 (1) : 33 - 33
[5] Warfarin overdoseSupratherapeutic INR and treatment non-compliance following intentional drug misuse: case report
Reactions Weekly, 2023, 1949 (1) : 415 - 415
[6] PrednisoloneNavicular avascular necrosis following treatment non-compliance and intentional drug misuse: case report
Reactions Weekly, 2025, 2055 (1) : 306 - 306
[7] GefitinibSensorineural hearing loss, treatment non-compliance and drug misuse
Reactions Weekly, 2023, 1986 (1) : 192 - 192
[8] PrednisoneLack of efficay and treatment non-compliance with intentional drug misuse
Reactions Weekly, 2024, 2009 (1) : 497 - 497
[9] Naltrexone/tapentadolCutaneous pseudoallergic reaction and drug dependence following drug abuse, drug withdrawal symptoms, treatment failure and treatment non-compliance
Reactions Weekly, 2024, 2004 (1) : 354 - 354
[10] BuprenorphineTreatment non-compliance and drug misuse
Reactions Weekly, 2024, 2002 (1) : 108 - 108

← 1 2 3 4 5 →